Clinical Trials
4 trialsNCT03233711 2026-05-29
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT04929028 2026-05-13
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT05643859 2026-01-15
Impact of Dietary Fiber Supplementation on Colonic Microbiome
OHSU Knight Cancer Institute
Phase NA Recruiting
NCT04927897 2025-07-28
DETECT
Maastricht Radiation Oncology
Recruiting